Sort by
Refine Your Search
-
the main means of informing conservation status. The advancement of technology, particularly camera traps, combined with their increased availability and reduced cost means that more reliable methods are
-
of devices to help participants monitor activity levels. Some studies have attempted to analyse factors that influence engagement in these types of programmes. One common finding from discussions with older
-
Development of an docetaxel-loaded implantable device for the localised treatment of prostate cancer
drug delivery technology designed for the sustained release of chemotherapy directly into cancer tissue thereby improving clinical performance. Prostate cancer is one of the most common types of cancer
-
requirements may be offered admission on a self-funded basis. Applicants who already hold an MRes or a doctoral degree or who have been registered on a programme of research leading to the award of an MRes
-
requirements may be offered admission on a self-funded basis. Applicants who already hold an MRes or a doctoral degree or who have been registered on a programme of research leading to the award of an MRes
-
of data driven biomedical analysis and introduce you to the UK Biobank, a world leading research resource that is growing in scale and significance and is central to the UK’s biomedical data science
-
. This hypoxic environment has a profound influence on tumour biology, eliciting the expression of pro-survival pathways, immune tolerance and resistance to radiotherapy.1 Indeed, hypoxia is currently recognized
-
doctoral degree or who have been registered on a programme of research leading to the award of an MRes or doctoral degree are NOT eligible to apply for an award. Applicants who hold or who are registered
-
admission requirements may be offered admission on a self-funded basis. Applicants who already hold an MRes or a doctoral degree or who have been registered on a programme of research leading to the award
-
platforms for studying tumour biology and testing drug efficacy in a personalised context [4]. By using panels of genetically diverse prostate cancer cell lines, researchers can mimic the molecular spectrum